Invitrogen Predicts Technology Will Revolutionize Genomics

Dec 21, 1998

Premium

CARLSBAD, Calif.--A new Invitrogen technology that can be used to rapidly clone and express genes will expedite functional validation to keep pace with strides being made in structural genomics and DNA chip-based expressional analysis, according to Invitrogen CEO Lyle Turner. The proprietary technology, amenable to any gene collection, was first tested using the yeast genome. Since October 1997, Invitrogen has cloned 6,000 and expressed 1,000 yeast genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

All So Similar

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A Very Long Time Ago Indeed

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

This Week in PNAS

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Genetic Condition to Drug Inspiration

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.

Featured White Papers

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Probe Design and In Vitro Validation Quick Start Guide

Aug

27

Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Oct

02

Featured Webinar

Utilization of Multiple Molecular Testing Methodologies to Aid in Lung Cancer Patient Management

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.

Main menu